Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on August 19, 2025
Cannabix Technologies delivers Marijuana Breath Test Hardware to Omega Laboratories Inc.
GlobeNewswire
·
August 19, 2025
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports that it has delivered multiple Cannabix Marijuana Breath Test (“MBT”) units to Omega …
Cingulate Inc. Reports Second Quarter 2025 Financial Results and Provides Recent Highlights
GlobeNewswire
·
August 19, 2025
Submitted New Drug Application (NDA) to the FDA for lead asset CTx-1301 Anticipate FDA Decision in Q4 2025 regarding NDA Acceptance with Potential PDUFA Date in Mid-2026 KANSAS CITY, Kan., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a …
Postbiotics Market Set to Surge: New Frontiers in Functional Foods and Skincare
GlobeNewswire
·
August 19, 2025
Delray Beach, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to research report published by MarketsandMarkets, The global postbiotics market is on an impressive upward trajectory, projected to increase from USD 146.7 million in 2025 to USD 224.8 million …
Walking Alone at Night is the Greatest Safety Fear of Women Nationwide -- Almost Half Say Safety Concerns Limit Daily Activities LogicMark Poll Reveals
GlobeNewswire
·
August 19, 2025
LOUISVILLE, Ky., Aug. 19, 2025 (GLOBE NEWSWIRE) -- A comprehensive new national survey commissioned by LogicMark, Inc. (OTC: LGMK), a provider of personal safety devices, related to women’s safety exposes a stark reality: walking alone at night dominates …
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July
GlobeNewswire
·
August 19, 2025
NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its highest-ever monthly …
Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call
GlobeNewswire
·
August 19, 2025
LITTLETON, Colo., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary …
Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ
GlobeNewswire
·
August 19, 2025
MELBOURNE, Australia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today …
BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis
GlobeNewswire
·
August 19, 2025
U.S. FDA has placed a clinical hold on the Phase 2b study as it reviews data submitted by BiomX on third-party nebulizer used to deliver BX004; no concerns were raised in the clinical hold notification regarding the BX004 drug candidate Enrollment and …
Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO
GlobeNewswire
·
August 19, 2025
Board addition served in the Trump Administration, overseeing 1,300 facilities serving more than 9 million veterans; New CFO has led finance and operations at companies including Northrop Grumman, Stanley Black …
Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador
GlobeNewswire
·
August 19, 2025
Partnership expands momentum for launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) today announced that Chris …
Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway
GlobeNewswire
·
August 19, 2025
SPC-15’s intranasal spray formulation meets safety standards for clinical trial development SARASOTA, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and …
SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors
GlobeNewswire
·
August 19, 2025
ALISO VIEJO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately held ophthalmic biotechnology company, today announced the appointment of Elizabeth (Liz) O’Farrell to its Board of Directors as an Independent Director and Chair of the …
Aptitude Development Expands Partnership with Counslr to Offer 24/7 Mental Health Support Across All Properties Nationwide
GlobeNewswire
·
August 19, 2025
NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Counslr, a leading B2B mental health and wellness platform, announced the nationwide expansion of its partnership with Aptitude Development, the national student housing organization. After a successful launch at …
Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
GlobeNewswire
·
August 19, 2025
BOSTON and ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of pulmonary arterial hypertension (“PAH”), …
Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
GlobeNewswire
·
August 19, 2025
AUSTIN, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, …
BreastCT.com Debuts as Go-To Resource for Breast CT Technology & Izotropic’s IzoView Device
GlobeNewswire
·
August 19, 2025
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging …
Milestone® Pharmaceuticals to Present at Upcoming Conferences
GlobeNewswire
·
August 19, 2025
MONTREAL and CHARLOTTE, N.C., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced President and CEO, Joe Oliveto, will participate in one-on-one meetings at the Wells Fargo Healthcare Conference, to take place …
ALX Oncology Doses First Patient in Phase 1 Dose Escalation Trial Evaluating ADC ALX2004 for the Treatment of EGFR-Expressing Solid Tumors
GlobeNewswire
·
August 19, 2025
- A potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors, ALX2004 is uniquely designed with every component optimized to maximize the therapeutic window -First-in-human trial of ALX2004 builds …
ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders
GlobeNewswire
·
August 19, 2025
UNIONDALE, NY, Aug. 19, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, today announced that it filed a definitive proxy statement (“DEF 14A”) …
All Kids Bike and "Mimi and Moto" Creators Collaborate on New Book Encouraging Kids to Ride Bikes
GlobeNewswire
·
August 19, 2025
Rapid City, South Dakota, Aug. 19, 2025 (GLOBE NEWSWIRE) -- RAPID CITY, S.D. –August 19, 2025 – All Kids Bike, the nonprofit organization on a mission to teach every kindergartner in America how to ride a bike, today announced a partnership with children’s …